Apolipoprotein E as a β-amyloid-independent factor in Alzheimer's disease
journal contributionposted on 12.04.2016 by Andrew B. Wolf, Jon Valla, Guojun Bu, Jungsu Kim, Mary Jo LaDu, Eric M. Reiman, Richard J. Caselli
Any type of content formally published in an academic journal, usually following a peer-review process.
APOE, which encodes apolipoprotein E, is the most prevalent and best established genetic risk factor for late-onset Alzheimer’s disease. Current understanding of Alzheimer’s disease pathophysiology posits an important role for apolipoprotein E in the disease cascade via its interplay with β-amyloid. However, evidence is also emerging for roles of apolipoprotein E in the disease process that are independent of β-amyloid. Particular areas of interest are lipid metabolism, tau pathology, neuroenergetics, neurodevelopment, synaptic plasticity, the neurovasculature, and neuroinflammation. The intent of this article is to review the literature in each of these areas.